Antiparasitic Drug Repurposing Research for Autoimmune Diseases

Research into antiparasitic drug repurposing research approaches for Autoimmune Diseases. AI-powered analysis of mechanisms, evidence, and clinical status.

About Antiparasitic Drug Repurposing Research

Investigation into repurposing antiparasitic drugs for cancer and neurological conditions. AI agents analyze fenbendazole, ivermectin, and mebendazole mechanisms and clinical evidence.

About Autoimmune Diseases

New autoimmune treatments in 2026: JAK inhibitors, precision immunotherapy, microbiome approaches. AI-analyzed across MS, lupus, RA, and Crohn's.

Standard of Care: Immunosuppressants (methotrexate, azathioprine), biologics (TNF inhibitors, IL-6 blockers, B-cell depleters), JAK inhibitors — primarily symptom control and flare prevention.